The VOR or TACAN RWY 12 approach in Tucson is a nonprecision instrument approach, primarily using VOR for civilian pilots, and features multiple DME-based altitude stepdowns. Pilots can initiate the ...
Add Yahoo as a preferred source to see more of our stories on Google. Headed to Tucson, Arizona, for some warmer winter weather? To see nearby national parks or even to visit the Pima Air & Space ...
LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a new strategic partnership with PromptCare, a leading ...
Vor Biopharma ( (VOR)) just unveiled an update. On December 31, 2025, Vor Biopharma Inc. entered into a separation agreement with its Chief Development Officer, Dr. Qing Zuraw, following her decision ...
Please provide your email address to receive an email when new articles are posted on . The integration of second-generation anti-vascular endothelial growth factor (VEGF) therapies into treatment ...
Hosted on MSN
Vor Biopharma approves stock option repricing plan
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Vor Biopharma (VOR) rose ~17% on Tuesday after J.P. Morgan initiated its coverage with an Overweight recommendation and a Dec. 2026 price target of $43, citing a potential blockbuster status for the ...
Vor Biopharma shares fell sharply Tuesday in premarket trading after the company priced its $100 million offering below recent trading prices. Shares traded 31% lower ahead of the morning bell at ...
Faricimab offers extended dosing intervals for DME, reducing injection frequency compared to traditional anti-VEGF therapies. The study showed improvements in CST and visual acuity in both ...
Shares of Vor Bio (Nasdaq: NASDAQ:VOR) rose after it reported that its partner, RemeGen (OTCPK:REGMF), met the main goal in a late-stage trial in China evaluating telitacicept for treating Sjögren’s ...
Durable medical equipment (DME) such as CPAP machines and hospital beds helps keep many patients out of expensive nursing home care and in their own homes. Unfortunately, creating the right payment ...
The recombinant fusion protein drug telitacicept from Remegen Co. Ltd. and Vor Bio Inc. has notched a phase III win in treating adults with IgA nephropathy. The clinical trial of the fusion protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results